The open question is whether policies should lean more heavily on markets, with their proven record of innovation and efficiency, or on government interventions that expand access but risk slowing progress.
getty
Calls to lower drug prices are back in the headlines, most recently with the president’s TrumpRx initiative aimed at easing the financial burden on patients and taxpayers by bringing U.S. drug prices closer to those paid abroad. The appeal is obvious: cheaper prescriptions today…
Continue Reading
News Source: www.forbes.com
Leave a Reply